Key Messages To Comprehend: 2023 Focused Update of the 2021 European Society of Cardiology Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure
Loading...
Files
Date
2023
Authors
Akyıldız, Zehra İlke
Journal Title
Journal ISSN
Volume Title
Publisher
Bishkek: Center for Scientific Research and Development of Education
Open Access Color
GOLD
Green Open Access
No
OpenAIRE Downloads
OpenAIRE Views
Publicly Funded
No
BIP! Indicators
Impulse
Average
Influence
Average
Popularity
Average
Abstract
[No abstract available]
Description
Keywords
acetazolamide, amino terminal pro brain natriuretic peptide, angiotensin receptor antagonist, beta adrenergic receptor blocking agent, canagliflozin, dapagliflozin, dipeptidyl carboxypeptidase inhibitor, diuretic agent, empagliflozin, finerenone, furosemide, hydrochlorothiazide, insulin, iron, iron isomaltose, loop diuretic agent, mineralocorticoid antagonist, sodium glucose cotransporter 2 inhibitor, sotagliflozin, torasemide, acute heart failure, add on therapy, adverse outcome, blood pressure, cardiologist, cardiology, cardiovascular mortality, cardiovascular risk, cerebrovascular accident, chronic disease, chronic kidney failure, comorbidity, coronavirus disease 2019, death, diabetes mellitus, diabetic ketoacidosis, diabetic nephropathy, disease course, drug efficacy, drug safety, drug tolerability, Editorial, estimated glomerular filtration rate, European, evaluation study, evidence based practice, follow up, health care access, heart failure, heart failure with preserved ejection fraction, heart failure with reduced ejection fraction, heart infarction, heart left ventricle ejection fraction, heart muscle revascularization, hemodialysis, hemodialysis patient, hospital patient, hospitalization, human, iron deficiency, iron therapy, medical society, meta analysis (topic), morbidity, non insulin dependent diabetes mellitus, outcomes research, practice guideline, prognosis, randomized controlled trial (topic), risk reduction, sensitivity analysis, treatment outcome, tricuspid valve repair, treatment, sodium–glucose co-transporter 2 inhibitors, RC666-701, 1, heart failure, Diseases of the circulatory (Cardiovascular) system, guidelines, comorbidities, angiotesin receptor and neprilysin inhibitor, continuous medical education
Fields of Science
Citation
WoS Q
N/A
Scopus Q
Q4
OpenCitations Citation Count
N/A
Source
Heart, Vessels and Transplantation
Volume
7
Issue
4
Start Page
End Page
PlumX Metrics
Citations
Scopus : 0
Captures
Mendeley Readers : 10
Google Scholar™
